Endoscopy 2003; 35(8): 679-682
DOI: 10.1055/s-2003-41518
Original Article

© Georg Thieme Verlag Stuttgart · New York

Safety of Nonanesthetist Sedation with Propofol for Outpatient Colonoscopy and Esophagogastroduodenoscopy

D.  Külling1 , R.  Rothenbühler1 , W.  Inauen1
  • 1Gastroenterology Center, Bürgerspital, Solothurn, Switzerland
Further Information

Publication History

Submitted 1 October 2002

Accepted after Revision 19 March 2003

Publication Date:
20 August 2003 (online)

Background and Study Aims: In our endoscopy service, nonanesthetists administered propofol sedation has been used in more than 8000 procedures during the past 3 years. This study prospectively assessed the safety of propofol sedation in outpatient colonoscopy and esophagogastroduodenoscopy (EGD).
Patients and Methods: A total of 300 consecutive outpatients (mean age 53, range 14-94) were enrolled in the study (139 colonoscopies, 161 EGDs). After an initial dose of 0.5 mg/kg (ASA I-II and age ≤70) or 0.25 mg/kg (ASA >III or age >70 years), propofol was titrated in 10 mg boluses to a steady state of sedation by the endoscopy nurse under the endoscopist's supervision. Colonoscopy patients also received 25 mg pethidine (meperidine) and 20 mg butylscopolamine, whereas EGDs were performed with propofol sedation alone, without topical pharyngeal anesthesia. In addition to standard monitoring with pulse oximetry and automated sphygmomanometry, patients were also observed with sidestream capnography or measurement of electrocardiographic impedance changes, providing real-time graphic assessment of respiratory activity. All patients were given oxygen 2 L/min by nasal cannula during the entire procedure.
Results: Mean dosages of 157 mg (range 70-340) and 180 mg (60-400) propofol were administered for colonoscopy and EGD procedures, respectively. No episodes of apnea occurred. The oxygen saturation fell below 90 % for short periods of time in 11 patients (3.7 %). Three patients required a temporary increase in oxygen delivery. No assisted ventilation was necessary. In 22 patients (7.3 %), the mean blood pressure temporarily decreased below 50 mmHg. Two patients received a 500-ml infusion of normal saline.
Conclusions: Propofol can be safely administered for sedation during colonoscopy and esophagogastroduodenoscopy by nonanesthetists who are familiar with the pharmacological properties and use of this drug.


  • 1 Carlsson U, Grattidge P. Sedation for upper gastrointestinal endoscopy: a comparative study of propofol and midazolam.  Endoscopy. 1995;  27 240-243
  • 2 Wehrmann T, Kokabpick S, Lembcke B. et al . Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study.  Gastrointest Endosc. 1999;  49 677-683
  • 3 Jung M, Hofmann C, Kiesslich R, Brackertz A. Improved sedation in diagnostic and therapeutic ERCP: propofol is an alternative to midazolam.  Endoscopy. 2000;  32 233-238
  • 4 Koshy G, Nair S, Norkus E P, Hertan H I, Pitchumoni C S. Propofol versus midazolam and meperidine for conscious sedation in GI endoscopy.  Am J Gastroenterol. 2000;  95 1476-1479
  • 5 Vargo J J, Zuccaro G, Dumot J A. et al . Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial.  Gastroenterology. 2002;  123 8-16
  • 6 Sipe B W, Rex D K, Latinovich D. et al . Propofol versus midazolam/meperidine for outpatient colonoscopy: administration by nurses supervised by endoscopists.  Gastrointest Endosc. 2002;  55 815-825
  • 7 Roseveare C, Seavell C, Patel P. et al . Patient-controlled sedation and analgesia, using propofol and alfentanil, during colonoscopy: a prospective randomized controlled trial.  Endoscopy. 1998;  30 768-773
  • 8 Külling D, Fantin A C, Biro P. et al . Safer colonoscopy with patient-controlled analgesia and sedation with propofol and alfentanil.  Gastrointest Endosc. 2001;  54 1-7
  • 9 Ng J M, Kong C F, Nyam D. Patient-controlled sedation with propofol for colonoscopy.  Gastrointest Endosc. 2001;  54 8-13
  • 10 Kaddu R, Bhattacharya D, Metriyakool K. et al . Propofol compared with general anesthesia for pediatric GI endoscopy: is propofol better?.  Gastrointest Endosc. 2002;  55 27-32
  • 11 Owens W D, Felts F A, Spitznagel E L. ASA physical status classification: a study of consistency of ratings.  Anesthesiology. 1978;  49 239-243
  • 12 Vargo J J, Zuccaro G, Dumot J A. et al . Gastroenterologist-administered propofol for therapeutic upper endoscopy with graphic assessment of respiratory activity: a case series.  Gastrointest Endosc. 2000;  52 250-255
  • 13 Vargo J J, Zuccaro G, Dumot J A. et al . Automated graphic assessment of respiratory activity is superior to pulse oximetry and visual assessment for the detection of early respiratory depression during therapeutic upper endoscopy.  Gastrointest Endosc. 2002;  55 826-831
  • 14 Bell G D. Premedication, preparation, and surveillance.  Endoscopy. 2002;  34 2-12
  • 15 Bell G D, Charlton J E. Colonoscopy: is sedation necessary and is there any role for intravenous propofol?.  Endoscopy. 2000;  32 264-267
  • 16 Heuss L T, Schnieper P, Drewe J, Pfimlin E, Beglinger C. Safety of propofol for conscious sedation during endoscopic procedures: a prospective study [abstract].  Gastrointest Endosc. 2002;  55 AB144
  • 17 Rex D K, Overley C, Kinser K. et al . Safety of propofol administration by registered nurses with gastroenterologist supervision in 2000 endoscopic cases.  Am J Gastroenterol. 2002;  97 1159-1163
  • 18 Gross J B, Bailey P L, Connis R T. et al . Practice guidelines for sedation and analgesia by non-anesthesiologists.  Anesthesiology. 2002;  96 1004-1017

D. Külling, M.D.

GastroZentrum Hirslanden

Seefeldstrasse 214 · 8008 Zürich · Switzerland·

Fax: +41-1-4217007

Email: daniel.kuelling@gmx.ch